Global Metabolomics Biomarker Market Growth (Status and Outlook) 2022-2028
- LP 4925450
- 104 Pages
- March 2022
- Medical Devices
The United States Metabolomics Biomarker market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabolomics Biomarker market, reaching US$ million by the year 2028. As for the Europe Metabolomics Biomarker landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metabolomics Biomarker players cover Biocrates Life Sciences, Biomark Diagnostics, Chenomx, and Creative Proteomics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabolomics Biomarker market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Protein Marker
Nucleic Acid Marker
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metabolomics Biomarker Market Size 2017-2028
2.1.2 Metabolomics Biomarker Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Metabolomics Biomarker Segment by Type
2.2.1 Protein Marker
2.2.2 Nucleic Acid Marker
2.3 Metabolomics Biomarker Market Size by Type
2.3.1 Metabolomics Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
2.4 Metabolomics Biomarker Segment by Application
2.4.1 Toxicological studies
2.4.2 Drug testing
2.4.3 Cancer
2.4.4 Cardiovascular disorders
2.4.5 Neurological disorders
2.4.6 Inborn errors of metabolism
2.5 Metabolomics Biomarker Market Size by Application
2.5.1 Metabolomics Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
3 Metabolomics Biomarker Market Size by Player
3.1 Metabolomics Biomarker Market Size Market Share by Players
3.1.1 Global Metabolomics Biomarker Revenue by Players (2020-2022)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2020-2022)
3.2 Global Metabolomics Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Metabolomics Biomarker by Regions
4.1 Metabolomics Biomarker Market Size by Regions (2017-2022)
4.2 Americas Metabolomics Biomarker Market Size Growth (2017-2022)
4.3 APAC Metabolomics Biomarker Market Size Growth (2017-2022)
4.4 Europe Metabolomics Biomarker Market Size Growth (2017-2022)
4.5 Middle East & Africa Metabolomics Biomarker Market Size Growth (2017-2022)
5 Americas
5.1 Americas Metabolomics Biomarker Market Size by Country (2017-2022)
5.2 Americas Metabolomics Biomarker Market Size by Type (2017-2022)
5.3 Americas Metabolomics Biomarker Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabolomics Biomarker Market Size by Region (2017-2022)
6.2 APAC Metabolomics Biomarker Market Size by Type (2017-2022)
6.3 APAC Metabolomics Biomarker Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Metabolomics Biomarker by Country (2017-2022)
7.2 Europe Metabolomics Biomarker Market Size by Type (2017-2022)
7.3 Europe Metabolomics Biomarker Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metabolomics Biomarker by Region (2017-2022)
8.2 Middle East & Africa Metabolomics Biomarker Market Size by Type (2017-2022)
8.3 Middle East & Africa Metabolomics Biomarker Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Metabolomics Biomarker Market Forecast
10.1 Global Metabolomics Biomarker Forecast by Regions (2023-2028)
10.1.1 Global Metabolomics Biomarker Forecast by Regions (2023-2028)
10.1.2 Americas Metabolomics Biomarker Forecast
10.1.3 APAC Metabolomics Biomarker Forecast
10.1.4 Europe Metabolomics Biomarker Forecast
10.1.5 Middle East & Africa Metabolomics Biomarker Forecast
10.2 Americas Metabolomics Biomarker Forecast by Country (2023-2028)
10.2.1 United States Metabolomics Biomarker Market Forecast
10.2.2 Canada Metabolomics Biomarker Market Forecast
10.2.3 Mexico Metabolomics Biomarker Market Forecast
10.2.4 Brazil Metabolomics Biomarker Market Forecast
10.3 APAC Metabolomics Biomarker Forecast by Region (2023-2028)
10.3.1 China Metabolomics Biomarker Market Forecast
10.3.2 Japan Metabolomics Biomarker Market Forecast
10.3.3 Korea Metabolomics Biomarker Market Forecast
10.3.4 Southeast Asia Metabolomics Biomarker Market Forecast
10.3.5 India Metabolomics Biomarker Market Forecast
10.3.6 Australia Metabolomics Biomarker Market Forecast
10.4 Europe Metabolomics Biomarker Forecast by Country (2023-2028)
10.4.1 Germany Metabolomics Biomarker Market Forecast
10.4.2 France Metabolomics Biomarker Market Forecast
10.4.3 UK Metabolomics Biomarker Market Forecast
10.4.4 Italy Metabolomics Biomarker Market Forecast
10.4.5 Russia Metabolomics Biomarker Market Forecast
10.5 Middle East & Africa Metabolomics Biomarker Forecast by Region (2023-2028)
10.5.1 Egypt Metabolomics Biomarker Market Forecast
10.5.2 South Africa Metabolomics Biomarker Market Forecast
10.5.3 Israel Metabolomics Biomarker Market Forecast
10.5.4 Turkey Metabolomics Biomarker Market Forecast
10.5.5 GCC Countries Metabolomics Biomarker Market Forecast
10.6 Global Metabolomics Biomarker Forecast by Type (2023-2028)
10.7 Global Metabolomics Biomarker Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Information
11.1.2 Biocrates Life Sciences Metabolomics Biomarker Product Offered
11.1.3 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biocrates Life Sciences Main Business Overview
11.1.5 Biocrates Life Sciences Latest Developments
11.2 Biomark Diagnostics
11.2.1 Biomark Diagnostics Company Information
11.2.2 Biomark Diagnostics Metabolomics Biomarker Product Offered
11.2.3 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Biomark Diagnostics Main Business Overview
11.2.5 Biomark Diagnostics Latest Developments
11.3 Chenomx
11.3.1 Chenomx Company Information
11.3.2 Chenomx Metabolomics Biomarker Product Offered
11.3.3 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Chenomx Main Business Overview
11.3.5 Chenomx Latest Developments
11.4 Creative Proteomics
11.4.1 Creative Proteomics Company Information
11.4.2 Creative Proteomics Metabolomics Biomarker Product Offered
11.4.3 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Creative Proteomics Main Business Overview
11.4.5 Creative Proteomics Latest Developments
11.5 Evotec
11.5.1 Evotec Company Information
11.5.2 Evotec Metabolomics Biomarker Product Offered
11.5.3 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Evotec Main Business Overview
11.5.5 Evotec Latest Developments
11.6 Human Metabolome Technologies
11.6.1 Human Metabolome Technologies Company Information
11.6.2 Human Metabolome Technologies Metabolomics Biomarker Product Offered
11.6.3 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Human Metabolome Technologies Main Business Overview
11.6.5 Human Metabolome Technologies Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Metabolomics Biomarker Product Offered
11.7.3 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Metabolomic Diagnostics
11.8.1 Metabolomic Diagnostics Company Information
11.8.2 Metabolomic Diagnostics Metabolomics Biomarker Product Offered
11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Metabolomic Diagnostics Main Business Overview
11.8.5 Metabolomic Diagnostics Latest Developments
11.9 Metabolon
11.9.1 Metabolon Company Information
11.9.2 Metabolon Metabolomics Biomarker Product Offered
11.9.3 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Metabolon Main Business Overview
11.9.5 Metabolon Latest Developments
11.10 Ovid Therapeutics
11.10.1 Ovid Therapeutics Company Information
11.10.2 Ovid Therapeutics Metabolomics Biomarker Product Offered
11.10.3 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ovid Therapeutics Main Business Overview
11.10.5 Ovid Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Metabolomics Biomarker Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Protein Marker
Table 3. Major Players of Nucleic Acid Marker
Table 4. Metabolomics Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Metabolomics Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
Table 7. Metabolomics Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Metabolomics Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
Table 10. Global Metabolomics Biomarker Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Metabolomics Biomarker Revenue Market Share by Player (2020-2022)
Table 12. Metabolomics Biomarker Key Players Head office and Products Offered
Table 13. Metabolomics Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Metabolomics Biomarker Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Metabolomics Biomarker Market Size Market Share by Regions (2017-2022)
Table 18. Americas Metabolomics Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Metabolomics Biomarker Market Size Market Share by Country (2017-2022)
Table 20. Americas Metabolomics Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
Table 22. Americas Metabolomics Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
Table 24. APAC Metabolomics Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Metabolomics Biomarker Market Size Market Share by Region (2017-2022)
Table 26. APAC Metabolomics Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
Table 28. APAC Metabolomics Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
Table 30. Europe Metabolomics Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Metabolomics Biomarker Market Size Market Share by Country (2017-2022)
Table 32. Europe Metabolomics Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
Table 34. Europe Metabolomics Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Metabolomics Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Metabolomics Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Metabolomics Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Metabolomics Biomarker
Table 43. Key Market Challenges & Risks of Metabolomics Biomarker
Table 44. Key Industry Trends of Metabolomics Biomarker
Table 45. Global Metabolomics Biomarker Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Metabolomics Biomarker Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Metabolomics Biomarker Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Metabolomics Biomarker Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Metabolomics Biomarker Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Metabolomics Biomarker Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biocrates Life Sciences Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 52. Biocrates Life Sciences Metabolomics Biomarker Product Offered
Table 53. Biocrates Life Sciences Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biocrates Life Sciences Main Business
Table 55. Biocrates Life Sciences Latest Developments
Table 56. Biomark Diagnostics Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 57. Biomark Diagnostics Metabolomics Biomarker Product Offered
Table 58. Biomark Diagnostics Main Business
Table 59. Biomark Diagnostics Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Biomark Diagnostics Latest Developments
Table 61. Chenomx Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 62. Chenomx Metabolomics Biomarker Product Offered
Table 63. Chenomx Main Business
Table 64. Chenomx Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Chenomx Latest Developments
Table 66. Creative Proteomics Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 67. Creative Proteomics Metabolomics Biomarker Product Offered
Table 68. Creative Proteomics Main Business
Table 69. Creative Proteomics Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Creative Proteomics Latest Developments
Table 71. Evotec Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 72. Evotec Metabolomics Biomarker Product Offered
Table 73. Evotec Main Business
Table 74. Evotec Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Evotec Latest Developments
Table 76. Human Metabolome Technologies Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 77. Human Metabolome Technologies Metabolomics Biomarker Product Offered
Table 78. Human Metabolome Technologies Main Business
Table 79. Human Metabolome Technologies Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Human Metabolome Technologies Latest Developments
Table 81. Merck Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 82. Merck Metabolomics Biomarker Product Offered
Table 83. Merck Main Business
Table 84. Merck Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Merck Latest Developments
Table 86. Metabolomic Diagnostics Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 87. Metabolomic Diagnostics Metabolomics Biomarker Product Offered
Table 88. Metabolomic Diagnostics Main Business
Table 89. Metabolomic Diagnostics Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Metabolomic Diagnostics Latest Developments
Table 91. Metabolon Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 92. Metabolon Metabolomics Biomarker Product Offered
Table 93. Metabolon Main Business
Table 94. Metabolon Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Metabolon Latest Developments
Table 96. Ovid Therapeutics Details, Company Type, Metabolomics Biomarker Area Served and Its Competitors
Table 97. Ovid Therapeutics Metabolomics Biomarker Product Offered
Table 98. Ovid Therapeutics Main Business
Table 99. Ovid Therapeutics Metabolomics Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Ovid Therapeutics Latest Developments
List of Figures
Figure 1. Metabolomics Biomarker Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metabolomics Biomarker Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Metabolomics Biomarker Market Size Market Share by Type in 2021
Figure 7. Metabolomics Biomarker in Toxicological studies
Figure 8. Global Metabolomics Biomarker Market: Toxicological studies (2017-2022) & ($ Millions)
Figure 9. Metabolomics Biomarker in Drug testing
Figure 10. Global Metabolomics Biomarker Market: Drug testing (2017-2022) & ($ Millions)
Figure 11. Metabolomics Biomarker in Cancer
Figure 12. Global Metabolomics Biomarker Market: Cancer (2017-2022) & ($ Millions)
Figure 13. Metabolomics Biomarker in Cardiovascular disorders
Figure 14. Global Metabolomics Biomarker Market: Cardiovascular disorders (2017-2022) & ($ Millions)
Figure 15. Metabolomics Biomarker in Neurological disorders
Figure 16. Global Metabolomics Biomarker Market: Neurological disorders (2017-2022) & ($ Millions)
Figure 17. Metabolomics Biomarker in Inborn errors of metabolism
Figure 18. Global Metabolomics Biomarker Market: Inborn errors of metabolism (2017-2022) & ($ Millions)
Figure 19. Global Metabolomics Biomarker Market Size Market Share by Application in 2021
Figure 20. Global Metabolomics Biomarker Revenue Market Share by Player in 2021
Figure 21. Global Metabolomics Biomarker Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Metabolomics Biomarker Market Size 2017-2022 ($ Millions)
Figure 23. APAC Metabolomics Biomarker Market Size 2017-2022 ($ Millions)
Figure 24. Europe Metabolomics Biomarker Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Metabolomics Biomarker Market Size 2017-2022 ($ Millions)
Figure 26. Americas Metabolomics Biomarker Value Market Share by Country in 2021
Figure 27. Americas Metabolomics Biomarker Consumption Market Share by Type in 2021
Figure 28. Americas Metabolomics Biomarker Market Size Market Share by Application in 2021
Figure 29. United States Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Metabolomics Biomarker Market Size Market Share by Region in 2021
Figure 34. APAC Metabolomics Biomarker Market Size Market Share by Application in 2021
Figure 35. China Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Metabolomics Biomarker Market Size Market Share by Country in 2021
Figure 42. Europe Metabolomics Biomarker Market Size Market Share by Type in 2021
Figure 43. Europe Metabolomics Biomarker Market Size Market Share by Application in 2021
Figure 44. Germany Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Metabolomics Biomarker Market Size Market Share by Application in 2021
Figure 52. Egypt Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Metabolomics Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 58. APAC Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 59. Europe Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 61. United States Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 62. Canada Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 65. China Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 66. Japan Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 67. Korea Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 69. India Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 70. Australia Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 71. Germany Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 72. France Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 73. UK Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 74. Italy Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 75. Russia Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 76. Spain Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 79. Israel Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Metabolomics Biomarker Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
